This Virtual Networking Event will provide a forum for the discussion of the development of infectious disease therapeutics based on biophysical analysis of microbial targets and the interaction of peptides, lipids, glycans and small molecules with these targets. Topics will also include unconventional approaches, including bacteriophages and nanotechnology.
This event is organized by Nejat Düzgüneş, who is a BPS member since 1973 and a Professor at the University of the Pacific in San Francisco, CA, USA. His contributions may be found at:
https://www.ncbi.nlm.nih.gov/sites/myncbi/1d_Hkpws_q2QF/bibliography/44912867/public/?sort=date&direction=ascending
The event will be held on October 14, 2020, from 8 am - 4 pm PDT
When is this in my time zone?
Biophysicists interested in this networking event are encouraged to submit a short abstract (100 words or so) to Nejat Düzgüneş at [email protected] by October 10, 2020
Event Speakers
Gary R. Whittaker
Department of Microbiology and Immunology, Cornell University, USA
Narcis Fernandez-Fuentes
Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, UK
Sebastian Pomplon
Department of Chemistry, Massachusetts Institute of Technology, USA
Ian A Wilson
Department of INtegrative Structural and Computational Biology, The Scripps Research Institute, USA
Nejat Düzgüneş
Department of Biomedical Sciences, Arthur A. Dugoni School of Dentistry, University of the Pacific, USA
Peter Kasson
Departments of Molecular Physiology and of Biomedical Engineering, University of Virginia, USA
Lela Vukovic
Department of Chemistry and Biochemistry, University of Texas at El Paso, USA
Luis Schang
Cornell University College of Veterinary Medicine, USA
Event Schedule
8-9 am |
Gary R Whitaker - "Structural modeling of SARS-CoV-2 spike protein" |
9-10 am |
Narcis Fernandez-Fuentes - "Design of peptides to target SARS-CoV-2-ACE2 interaction: The Pep/-Covid19 database" |
10-11 am |
Sebastian Pomplon - "Design of peptide inhibitors of SARS-CoV-2 S protein-mediated fusion" |
11 am - 12 pm |
Peter Kasson - "Mechanisms of influenza virus fusion" |
12 - 12:20 pm |
Lela Vukovic - "Adaptive Evolution of Peptide Inhibitors for Mutating SARS-CoV-2" |
1-2 pm |
Ian A Wilson - "Structural insights into the design of novel anti-influenza therapies" |
2-2:30 pm |
Nejat Düzgüneş - "A universal and versatile anti-influenza medicine" |
2:30 - 3:30 pm |
Luis Schang - "Antiviral molecules acting on virion lipids via biophysical mechanisms of action" |
3:30 - 4:00 pm |
Discussion and future directions |